Philips Agrees to Acquire SpectraWAVE to Expand AI-Enabled Coronary Imaging and Physiology Portfolio

December 15, 2025

Philips has agreed to acquire SpectraWAVE, a Bedford, Massachusetts-based developer of AI-enabled vascular imaging and coronary physiology assessment tools. The deal is intended to strengthen Philips’ image-guided therapy business by adding SpectraWAVE’s HyperVue Imaging System and X1-FFR software for intravascular imaging and angio-derived fractional flow reserve assessment.

Buyers
Philips
Targets
SpectraWAVE
Industry
Medical Devices
Location
Massachusetts, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.